Literature DB >> 23706810

Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates.

Jie Lu1, Wanyin Tao, Rui Li, Yu Xiang, Nan Zhang, Xiaogang Xiang, Qing Xie, Jin Zhong.   

Abstract

HCV genotype is a major determinant of clinical outcome, and GT1b HCV infection is the most difficult to treat and also the predominant genotype in East Asia and Europe. We developed 1b/JFH-1 inter-genotypic recombinants containing the structural genes (Core, E1, E2), p7 and the 1stTMD of NS2 directly from GT1b clinical isolates. Through a cloning selection strategy, we obtained 4 functional clones from 3 cases of GT1b patients' sera, which could produce infectious viruses in Huh7.5.1 cells. Sequencing analysis of recovered viruses from serial passage and reverse genetics revealed that adaptive mutations in the GT1b-originated region were enough for the enhancement of infectivity. A monoclonal antibody to E2 and original patient sera could efficiently block 3 of the viruses (26C3mt, 52B6mt and 79L9) while had little effect on 26C6mt viruses. The availability of 1b/JFH-1 chimeric viruses will be important for studies of isolate-specific neutralization and useful in evaluating antiviral therapies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706810     DOI: 10.1016/j.virol.2013.04.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.

Authors:  Yimin Tong; Qingchao Li; Rui Li; Yongfen Xu; Yu Pan; Junqi Niu; Jin Zhong
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.

Authors:  Dapeng Li; Markus von Schaewen; Xuesong Wang; Wanyin Tao; Yunfang Zhang; Li Li; Brigitte Heller; Gabriela Hrebikova; Qiang Deng; Alexander Ploss; Jin Zhong; Zhong Huang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Construction of a chimeric hepatitis C virus replicon based on a strain isolated from a chronic hepatitis C patient.

Authors:  Huang Cao; Wandi Zhu; Qingxia Han; Rongjuan Pei; Xinwen Chen
Journal:  Virol Sin       Date:  2014-01-20       Impact factor: 4.327

4.  A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate.

Authors:  Jie Lu; Yu Xiang; Wanyin Tao; Qingchao Li; Na Wang; Yongfeng Gao; Xiaogang Xiang; Qing Xie; Jin Zhong
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

5.  Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.

Authors:  Christian K Mathiesen; Jannick Prentoe; Luke W Meredith; Tanja B Jensen; Henrik Krarup; Jane A McKeating; Judith M Gottwein; Jens Bukh
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

6.  Design, Construction and Evaluation of 1a/JFH1 HCV Chimera by Replacing the Intergenotypic Variable Region.

Authors:  Faezeh Ghasemi; Majid Ghayour-Mobarhan; Alireza Pasdar; Hamid Pourianfar; Mohammad Reza Aghasadeghi; Hamed Gouklani; Zahra Meshkat
Journal:  Hepat Mon       Date:  2016-08-07       Impact factor: 0.660

7.  Phylogenetic analysis of HCV subgenotypes in patients from Sichuan province in China based on the NS5B region.

Authors:  Bin Nie; Guangjiong Zhang; Yongcan Guo; Qingfeng Li; Jinbo Liu; Zhiguang Tu
Journal:  Int J Mol Med       Date:  2015-08-24       Impact factor: 4.101

8.  Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody.

Authors:  Chunyan Yi; Jing Xia; Lan He; Zhiyang Ling; Xuesong Wang; Yu Yan; Jiangjun Wang; Xinhao Zhao; Weiguo Fan; Xiaoyu Sun; Ronghua Zhang; Sheng Ye; Rongguang Zhang; Yongfen Xu; Liyan Ma; Yaguang Zhang; Honglin Zhou; Zhong Huang; Junqi Niu; Gang Long; Junxia Lu; Jin Zhong; Bing Sun
Journal:  Cell Mol Immunol       Date:  2020-03-31       Impact factor: 11.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.